Skip to main content
. 2020 Sep 17;10:15253. doi: 10.1038/s41598-020-72190-5

Figure 3.

Figure 3

Analysis on vCSF-cfmtDNA integrity in NDDs and matched controls. Boxplots of vCSF-cfmtDNA integrity in NDD, showing (a) vCSF-cfmtDNA deletion level in NDDs and matched controls, (b) the comparative total vCSF-cfmtDNA heteroplasmic mutation rate in each NDD and matched controls, (c) the comparative non-synonymous vCSF-cfmtDNA heteroplasmic mutation rate in each NDD and matched controls and (d) the vCSF-cfmtDNA Ka/Ks(+ 1) for in each NDD and matched controls. Where AD = Alzheimer’s Disease, DLB = dementia with Lewy bodies, PSP = progressive supranuclear palsy, MND = motor neuron disease, FTD/VD = frontotemporal lobar dementia/vascular dementia and PD = Parkinson’s disease. Boxes show median, 25th and 75th percentile and whiskers show 95% confidence interval.